Compound Detail
CHEMBL493682
DENOPAMINE 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL493682 |
| Name | DENOPAMINE |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | VHSBBVZJABQOSG-INIZCTEOSA-N |
2
Targets
2
Activities
2
Assay Types
0
PK Parameters
20
Publications
5
Known Names
Molecular Properties
317.4
MW (Da)
2.28
ALogP
5
HBA
3
HBD
71.0
PSA (Ų)
0.65
QED
0
Ro5 Violations
8
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Activity Summary
EC50 1 meas. best 4.41
IC50 1 meas. best 4.33
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| NON-PROTEIN TARGET CHEMBL3879801 | EC50 | 4.41 | 4.41 | 39200.0 | 1 |
| Solute carrier family 22 member 1 CHEMBL5685 | IC50 | 4.33 | 4.33 | 46900.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| NON-PROTEIN TARGET | EC50 | = | 39200.0 | nM | 4.41 | Antiproliferative activity against mouse neural precursor cells by MTT assay | 17417631 |
| Solute carrier family 22 member 1 | IC50 | = | 46900.0 | nM | 4.33 | Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT... | 18788725 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 37468498 | 10.1038/s41467-023-40064-9 | Nuclear receptor subfamily 1 group I member 2 | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Progesterone receptor | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Thromboxane A2 receptor | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Androgen receptor | 3 |
| 17417631 | 10.1038/nchembio873 | NON-PROTEIN TARGET | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Histamine H3 receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-1A adrenergic receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Sodium-dependent dopamine transporter | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Prostaglandin G/H synthase 1 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Adenosine receptor A1 | 2 |
| 18788725 | 10.1021/jm8003152 | Solute carrier family 22 member 1 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Estrogen receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Sodium-dependent noradrenaline transporter | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Sodium-dependent serotonin transporter | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Adenosine receptor A3 | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | Muscarinic acetylcholine receptor M1 | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | Equilibrative nucleoside transporter 1 | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | Beta-2 adrenergic receptor | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | Beta-1 adrenergic receptor | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | Voltage-gated inwardly rectifying potassium channel KCNH2 | 1 |
Data from ChEMBL 36 via Core Engine